Komori
Sugi Holdings (7649) · InitiativeAdvanced

Regional Healthcare Collaboration, Promotion of Generic Drug Use, and Reinvention of Dispensing Operations

First written in FY2017-Q1. 27 of 36 entries say "Advanced", first in FY2018-Q1. Latest entry: FY2027-H1.

36entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2020-Q3 – FY2024-Q2AdvancedFY2025-H1 – FY2027-H12016: 220162017: 420172018: 220182019: 320192020: 320202021: 420212022: 420222023: 420232024: 220242025: 220252026: 62026
Same theme, other companies
Strengthening primary care pharmacy functions and advancing integrated community care and home healthcareA theme 14 companies write about · 0 as a headwind · 23 as a tailwind

The whole theme swung hardest in 2025: 1 of 10 companies on the "Worse" side.

9 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1AdvancedAnnual report

    「In the dispensing business, the Group proceeded with refurbishing dispensing rooms and waiting areas and strengthened its capacity to fill prescriptions requiring a high level of expertise and provide home-visit dispensing services by strengthening cooperation with medical institutions. It also strengthened prescription acquisition through measures including reviewing business hours. In addition, the Group worked to improve labor productivity by optimizing personnel deployment.」

    Strengthening the dispensing business has taken concrete form in refurbishing dispensing spaces, cooperation with medical institutions, capacity to handle prescriptions requiring a high level of expertise and home-visit dispensing services, reviewing business hours, and optimizing personnel deployment.
  2. FY2026AdvancedAnnual report

    「The Group proceeded with the expansion and refurbishment of dispensing rooms and waiting areas and, by enhancing pharmacists' specialized training and strengthening cooperation with medical institutions, developed the capacity to fill prescriptions requiring a high level of expertise and provide home-visit dispensing services, thereby increasing prescription acquisition.」

    The redevelopment of dispensing operations has progressed to include handling prescriptions requiring a high level of expertise and home-visit dispensing services, cooperation with medical institutions, specialized training, and improvements to dispensing spaces.
  3. FY2026-H1AdvancedAnnual report

    「The Group proceeded with the expansion and refurbishment of dispensing rooms and waiting areas and strengthened its capacity to fill prescriptions requiring a high level of expertise, thereby increasing the number of affiliated medical institutions and expanding its revenue base.」

    Strengthening the dispensing business has taken concrete form in expanding and refurbishing dispensing spaces, developing capacity to fill prescriptions requiring a high level of expertise, and increasing the number of affiliated medical institutions.
  4. FY2025AdvancedAnnual report

    「The Group expanded and refurbished dispensing rooms and waiting areas, strengthened its ability to fill prescriptions requiring a high level of expertise, and worked to expand the business of I&H株式会社, a major dispensing pharmacy operator that became a subsidiary in September 2024, thereby strengthening its revenue base.」

    Strengthening the dispensing business has taken concrete form in expanding I&H株式会社's business, filling prescriptions requiring a high level of expertise, and expanding dispensing spaces.
  5. FY2025-H1AdvancedAnnual report

    「The Group also promoted family pharmacists and family pharmacies by enhancing specialized training for pharmacists and developing an electronic prescription system.」

    Strengthening dispensing operations has taken concrete form in pharmacist training and development of an electronic prescription system.
  6. FY2025-Q1RestatedAnnual report

    「Against this backdrop, in the dispensing business, the Group proceeded with new pharmacy openings and expanded and refurbished dispensing rooms and waiting areas to handle the growing number of prescriptions filled, thereby seeking to further increase its market share. It also strengthened pharmacists' specialized training to promote family pharmacists and family pharmacies, and worked to increase the acquisition of prescriptions requiring a higher level of expertise, thereby strengthening its revenue base in the dispensing business.」

    The Group continues to strengthen the dispensing business through new pharmacy openings, expansion of dispensing spaces, specialized pharmacist training, and winning prescriptions requiring a higher level of expertise.
  7. FY2024-Q2AdvancedAnnual report

    「In the dispensing business, the Group proceeded with new pharmacy openings and actively expanded and refurbished dispensing rooms and waiting areas to handle the growing number of prescriptions filled. It also sought to promote patient-facing services by strengthening pharmacists' specialized training and worked to win prescriptions requiring high-value medications.」

    The expansion and redevelopment of the dispensing business have taken concrete form in new pharmacy openings, expansion of dispensing spaces, pharmacist training, and winning prescriptions requiring high-value medications.
  8. FY2024-Q1AdvancedAnnual report

    「Against this backdrop, in strengthening the pharmacy business we worked to increase sales by further promoting downloads of our family-pharmacy app, which has surpassed 1 million users, and by expanding and renovating pharmacy and waiting areas. We also pursued detailed optimization of personnel allocation to strengthen face-to-face services and stepped up the recruitment of pharmacists and medical administrative personnel.」

    Measures to strengthen the dispensing business have taken concrete form in promoting app use, expanding dispensing spaces, deploying personnel in patient-facing services, and recruiting pharmacists and medical administrative staff.
  9. FY2023AdvancedAnnual report

    「To handle the increasing number of prescriptions filled, the Group expanded and refurbished dispensing rooms and waiting areas at existing pharmacies, promoted downloads of its medication record app to improve patient convenience, and developed a network of pharmacies capable of handling electronic prescriptions, which began in January 2023.」

    The expansion and redevelopment of dispensing operations have taken concrete form in expanding dispensing spaces, promoting use of the medication record app, and developing a network of pharmacies capable of handling electronic prescriptions introduced in January 2023.
  10. FY2023-Q3AdvancedAnnual report

    「In the dispensing business, the Group proceeded with new pharmacy openings and worked to strengthen sales to nearby medical institutions, expand and refurbish dispensing rooms and waiting areas to handle the growing number of prescriptions filled, and improve patient convenience by offering its medication record app on an OEM basis.」

    Measures in the dispensing business have taken concrete form in new pharmacy openings and expansion and refurbishment of dispensing spaces, as well as stronger sales efforts to nearby medical institutions and OEM provision of the medication record app.
  11. FY2023-Q2AdvancedAnnual report

    「Against this backdrop, to expand the dispensing business, the Group proceeded with new pharmacy openings and worked to strengthen in-store and app-based communications with retail customers to increase dispensing service use, expand and refurbish dispensing rooms and waiting areas to handle the growing number of prescriptions filled, and promote task shifting from pharmacists to medical administrative staff to improve productivity.」

    Measures to expand the dispensing business have taken concrete form in new pharmacy openings, in-store and app-based communications, expansion and refurbishment of dispensing rooms and waiting areas, and task shifting from pharmacists to medical administrative staff.
  12. FY2023-Q1AdvancedAnnual report

    「Against this backdrop, to strengthen the dispensing business, the Group worked to strengthen sales, including promoting downloads of its family pharmacy app and expanding and refurbishing dispensing rooms and waiting areas, as well as improve productivity by promoting task shifting from pharmacists to medical administrative staff and developing dedicated hubs for home-visit dispensing services.」

    Measures to strengthen the dispensing business have taken concrete form in the family pharmacy app, expansion and refurbishment of dispensing spaces, task shifting from pharmacists to medical administrative staff, and development of dedicated hubs for home-visit dispensing services.
  13. FY2022AdvancedAnnual report

    「In addition, to deepen regional healthcare cooperation, the Group entered into a basic agreement on industry-academia cooperation in regional healthcare with Fujita Academy, an educational corporation that operates across a broad range from regional to advanced medicine and has multiple medical institutions, including Fujita Health University Hospital, which has the largest number of general hospital beds in Japan, as affiliated facilities.」

    Regional healthcare cooperation has taken concrete form in the signing of a basic agreement with Fujita Academy on industry-academia cooperation in regional healthcare.
  14. FY2022-Q3AdvancedAnnual report

    「To further expand the dispensing business, the Group proceeded with new pharmacy openings and worked to expand and refurbish dispensing rooms and waiting areas, strengthen communications to increase dispensing service use, promote downloads of its family pharmacy app, and actively recruit pharmacists.」

    The measures to expand the dispensing business have taken concrete form in new pharmacy openings, expansion of dispensing spaces, communications to increase service use, app utilization, and pharmacist recruitment.
  15. FY2022-Q2AdvancedAnnual report

    「Against this backdrop, in the dispensing business, the Group proceeded with new pharmacy openings and worked to further expand the dispensing business and improve productivity by strengthening in-store and app-based communication with retail customers to increase the rate of combined dispensing service use, and by expanding and refurbishing dispensing rooms and waiting areas.」

    Specific measures in the dispensing business include opening new pharmacies, in-store and app-based communication with retail customers, increasing the rate of combined dispensing service use, and expanding and refurbishing dispensing rooms and waiting areas.
  16. FY2022-Q1AdvancedAnnual report

    「Against this backdrop, in the dispensing business, the Group worked to increase the number of prescriptions filled through new pharmacy openings, improve efficiency by introducing dispensing equipment, and open hub pharmacies to expand home-visit dispensing services.」

    Specific initiatives in the dispensing business include opening new pharmacies, introducing dispensing equipment, and opening hub pharmacies to expand home-visit dispensing services.
  17. FY2021AdvancedAnnual report

    「Expansion of the number of pharmacies offering dispensing services to further expand the dispensing business」

    As part of its strategy to expand the dispensing business, the Group continues to open additional pharmacies offering dispensing services.
  18. FY2021-Q3AdvancedAnnual report

    「Promoting counseling-based sales, a core strength since the company's founding, adding stores that provide dispensing services, and introducing the "kakari" app, which connects pharmacies and patients digitally and supports the transformation of pharmacies into patients' primary pharmacies following the September 2020 revision of the Pharmaceuticals and Medical Devices Act」

    In addition to adding stores that provide dispensing services, the company has developed concrete plans to connect patients and pharmacies digitally following the revision of the Pharmaceuticals and Medical Devices Act and to introduce an app supporting the transformation of pharmacies into patients' primary pharmacies.
  19. FY2021-Q2AdvancedAnnual report

    「The company worked to strengthen consultation services and introduce and prepare to roll out new operating procedures, including medication follow-up and online medication guidance, to enhance services for patients.」

    Regarding the enhancement of dispensing and patient services, the company has developed concrete plans to strengthen consultation services and introduce and prepare to roll out new operating procedures, including medication follow-up and online medication guidance.
  20. FY2020AdvancedAnnual report

    「Strengthening relationships with medical institutions and expanding stores attached to medical institutions to support further expansion of the dispensing business」

    As measures to expand the dispensing business, the company explicitly cites strengthening relationships with medical institutions and expanding stores attached to medical institutions.
  21. FY2020-Q3AdvancedAnnual report

    「Specifically, the company worked to strengthen its customer-service structure centered on its core strength of counseling, deepen cooperation with hospitals, open a pharmacy on the premises of a national university hospital to provide advanced medical care, actively recruit and enhance training and education for medical administrative staff to improve dispensing productivity, and provide specific health guidance to dependents through registered dietitians for insurers including health insurance societies and National Health Insurance societies.」

    The company is deepening cooperation with hospitals, with plans taking concrete form to open a pharmacy on the premises of a national university hospital to provide advanced medical care.
  22. FY2020-Q2RestatedAnnual report

    「Expanding stores with attached clinics to support further growth in the dispensing business」

    To grow the dispensing business, the company continues to pursue the expansion of stores with attached clinics as a strategic measure.
  23. FY2020-Q1RestatedAnnual report

    「Home healthcare initiatives and the expansion of stores with attached clinics to support further growth in the dispensing business」

    To grow the dispensing business, the company continues to expand home healthcare and stores with attached clinics.
  24. FY2019AdvancedAnnual report

    「Strengthening cooperation with medical institutions and expanding stores with attached clinics to support further growth in the dispensing business」

    As growth measures for the dispensing business, the company specifically cites strengthening cooperation with medical institutions and expanding stores with attached clinics.
  25. FY2018AdvancedAnnual report

    「Measures to increase the number of prescriptions filled, including promoting the use of generic drugs by expanding the range of generic products handled, conducting education on specific diseases in cooperation with government and medical institutions, and strengthening the provision of centralized medication-information management services using medication notebooks」

    In addition to generic drugs, education on specific diseases and centralized medication-information management, the company describes the introduction of dispensing-support equipment to improve pharmacists' efficiency and create time for home dispensing services and health consultations.
  26. FY2018-Q3RestatedAnnual report

    「Measures to increase the number of prescriptions filled, including promoting the use of generic drugs, strengthening education on specific diseases, and enhancing the provision of centralized medication-information management services」

    The company continues to promote the use of generic drugs, education on specific diseases and centralized medication-information management services as measures to increase the number of prescriptions filled.
  27. FY2018-Q2RestatedAnnual report

    「Measures to increase the number of prescriptions filled, including promoting the use of generic drugs, strengthening education on specific diseases, and enhancing the provision of centralized medication-information management services」

    The company continues to promote generic drugs, education on specific diseases and centralized medication-information management services as measures to increase the number of prescriptions filled.
  28. FY2018-Q1AdvancedAnnual report

    「Initiatives to increase the number of prescriptions filled, including providing education for specific diseases in cooperation with government and medical institutions, offering a centralized medication-information management service using medication notebooks, and improving pharmacists' productivity through a dispensing system rebuilt last year」

    To increase the number of prescriptions filled, the company has specified concrete initiatives ranging from cooperation with government and medical institutions and centralized medication-information management to the use of its rebuilt dispensing system.
  29. FY2017RestatedAnnual report

    「The company's principal business is operating community healthcare-oriented drugstores that sell pharmaceuticals, health foods, cosmetics and daily necessities, while also providing prescription dispensing services and home healthcare in cooperation with local healthcare professionals.」

    As a community healthcare-oriented drugstore operator, the company identifies prescription dispensing, cooperation with healthcare professionals and home healthcare as its business activities.
  30. FY2017-Q3RestatedAnnual report

    「Reviewing and rebuilding dispensing operations and systems from a forward-looking perspective to improve pharmacists' productivity」

    The company continues to review dispensing operations and systems to improve pharmacists' productivity.
  31. FY2017-Q2RestatedAnnual report

    「Further collaboration with neighboring medical institutions, promoting the use of generic drugs by expanding the range of products handled, and reviewing and rebuilding dispensing operations and systems from a forward-looking perspective to improve pharmacists' productivity」

    The company continues to collaborate with medical institutions, promote the use of generic drugs, and review dispensing operations and systems.
  32. FY2017-Q1First statedAnnual report

    「We will further strengthen cooperation with nearby medical institutions, promote the use of generic drugs by expanding the range of products handled, and comprehensively review and rebuild pharmacy operations and systems from a forward-looking perspective to improve pharmacists’ productivity.」

    The group identifies cooperation with local healthcare providers, greater use of generic drugs and the review of pharmacy operations and systems as measures to strengthen pharmacy functions.
Moved together

"Further Store Expansion" moved the same way as this thread, in the same document, in 25 of its 36 moves.

252422161414★123456
  1. ★This thread
  2. 1Further Store Expansion25×
  3. 2Clarifying and differentiating business formats24×
  4. 3Expansion of the Store Network Through New Openings and Renovations22×
  5. 4Rebuilding store formats and store types16×
  6. 5Swiftly capturing growth opportunities, including M&A14×
  7. 6Increase in prescription dispensing14×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Sugi Holdings yet. It last moved in the General Meetings of Shareholders of 2026-04-28: "Advanced".
Regional Healthcare Collaboration, Promotion of Generic Drug Use, and Reinvention of Dispensing Operations | SUGI HOLDINGS Co.,LTD. (7649) | Komori